| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NM0295-159 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/nm0295-159 |
| P698 | PubMed publication ID | 7585014 |
| P50 | author | Lisa Freund | Q67484963 |
| P2093 | author name string | M B Denckla | |
| A L Reiss | |||
| M T Abrams | |||
| R Greenlaw | |||
| P2860 | cites work | Individual-specific ‘fingerprints’ of human DNA | Q22122410 |
| The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein | Q28117885 | ||
| Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2 | Q28237519 | ||
| Mechanisms and Functions of Cell Death | Q28261655 | ||
| Characterization and localization of the FMR-1 gene product associated with fragile X syndrome | Q28270283 | ||
| Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome | Q28273791 | ||
| Selection in blood cells from female carriers of the fragile X syndrome: inverse correlation between age and proportion of active X chromosomes carrying the full mutation | Q33597898 | ||
| C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. | Q34322094 | ||
| Frontal-subcortical circuits and human behavior | Q34352930 | ||
| Fine structure of the human FMR1 gene | Q34357343 | ||
| Molecular genetics of cell death in the nematode Caenorhabditis elegans | Q35615509 | ||
| Neuroanatomy of fragile X syndrome: the temporal lobe | Q36734713 | ||
| MRI-based hippocampal volume measurements in epilepsy | Q36752473 | ||
| Fragile X syndrome: growth, development, and intellectual function | Q38595527 | ||
| Intelligence and cognitive profile in the fra(X) syndrome: a longitudinal study in 18 fra(X) boys. | Q38910708 | ||
| Programmed cell death: implications for neuropsychiatric disorders | Q40699849 | ||
| Neuropsychological dimensions of the fragile X syndrome: support for a non-dominant hemisphere dysfunction hypothesis | Q41197040 | ||
| Absence of expression of the FMR-1 gene in fragile X syndrome | Q41669091 | ||
| The trajectory of cognitive development in males with fragile X syndrome | Q42125209 | ||
| Alternative splicing in the fragile X gene FMR1. | Q42623011 | ||
| Neuroanatomy of fragile X syndrome: the posterior fossa | Q43827613 | ||
| Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome | Q44959699 | ||
| The young adult human brain: an MRI-based morphometric analysis | Q48098839 | ||
| Lithium induces apoptosis in immature cerebellar granule cells but promotes survival of mature neurons | Q48144979 | ||
| The effects of X monosomy on brain development: monozygotic twins discordant for Turner's syndrome | Q48251086 | ||
| Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat | Q48255852 | ||
| Adult fragile X syndrome. Clinico-neuropathologic findings | Q48545759 | ||
| Analysis of neocortex in three males with the fragile X syndrome | Q48619801 | ||
| Behavioral phenotype of fragile X syndrome: DSM-III-R autistic behavior in male children. | Q50305656 | ||
| Fragile X syndrome: genetic predisposition to psychopathology. | Q50307623 | ||
| Behavior problems of young girls with fragile X syndrome: factor scores on the Conners' Parent's Questionnaire. | Q51132627 | ||
| Molecular-neurobehavioral associations in females with the fragile X full mutation. | Q52024864 | ||
| Frequency and stability of the fragile X premutation. | Q52028259 | ||
| KH domains within the FMR1 sequence suggest that fragile X syndrome stems from a defect in RNA metabolism. | Q52034009 | ||
| Cognitive profiles of boys with the fragile X syndrome. | Q52070434 | ||
| Individual variation and specific cognitive deficits in the fra(X) syndrome. | Q52073638 | ||
| Cognitive profiles associated with the fra(X) syndrome in males and females. | Q52099826 | ||
| Syntactic delay and pragmatic deviance in the language of fragile X males. | Q52237868 | ||
| Developmental implications of changing trajectories of IQ in males with fragile X syndrome. | Q52242088 | ||
| Longitudinal IQ changes in fragile X males | Q69402197 | ||
| Longitudinal changes in IQ among fragile X females: a preliminary multicenter analysis | Q72761267 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 159-167 | |
| P577 | publication date | 1995-02-01 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | Neurodevelopmental effects of the FMR-1 full mutation in humans | |
| P478 | volume | 1 |
| Q36016303 | 3D pattern of brain abnormalities in Fragile X syndrome visualized using tensor-based morphometry |
| Q35550111 | A cerebellar tremor/ataxia syndrome among fragile X premutation carriers |
| Q41141324 | A controlled study of longitudinal IQ changes in females and males with fragile X syndrome |
| Q51976529 | A neuropsychological profile of attention deficits in young males with fragile X syndrome. |
| Q37439568 | A voxel-based morphometry comparison of regional gray matter between fragile X syndrome and autism |
| Q35317895 | Aberrant frontal lobe maturation in adolescents with fragile X syndrome is related to delayed cognitive maturation |
| Q34568411 | Animal models of restricted repetitive behavior in autism |
| Q33515289 | Applications of multivariate pattern classification analyses in developmental neuroimaging of healthy and clinical populations |
| Q73190596 | Aspects of skeletal development in fragile X syndrome fetuses |
| Q37611383 | Augmented noncanonical BMP type II receptor signaling mediates the synaptic abnormality of fragile X syndrome. |
| Q38575839 | Autism: Oxytocin, serotonin, and social reward |
| Q40835732 | Autism: the point of view from fragile X studies |
| Q50302318 | Autistic behaviors among girls with fragile X syndrome. |
| Q55435881 | Basal ganglia involvement in ARX patients: The reason for ARX patients very specific grasping? |
| Q46657492 | Blink rate in boys with fragile X syndrome: preliminary evidence for altered dopamine function |
| Q39240792 | Brain morphology in autism and fragile X syndrome correlates with social IQ: first report from the Canadian-Swiss-Egyptian Neurodevelopmental Study |
| Q37276242 | Cerebral dysgeneses associated with chromosomal disorders |
| Q30703355 | Cerebral growth in Fragile X syndrome: review and comparison with Down syndrome |
| Q22242378 | Childhood developmental disorders: an academic and clinical convergence point for psychiatry, neurology, psychology and pediatrics |
| Q48797273 | Cognitive, behavioral, and neuroanatomical assessment of two unrelated male children expressing FRAXE. |
| Q28705565 | Connecting genes to brain in the autism spectrum disorders |
| Q52012797 | Contribution of the FMR1 gene mutation to human intellectual dysfunction |
| Q37043811 | Craniofacial characteristics of fragile X syndrome in mouse and man. |
| Q35187186 | Developmental malformation of the corpus callosum: a review of typical callosal development and examples of developmental disorders with callosal involvement |
| Q48971023 | Differential impact of the FMR-1 full mutation on memory and attention functioning : a neuropsychological perspective. |
| Q38554191 | Discourse processing in women with fragile x syndrome: evidence for a deficit establishing coherence |
| Q35027861 | Discrimination learning and attentional set formation in a mouse model of Fragile X. |
| Q47071627 | Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest |
| Q37372367 | Effects of stimulus salience on touchscreen serial reversal learning in a mouse model of fragile X syndrome |
| Q51985551 | Eighth International workshop on the fragile X syndrome and X-linked mental retardation, August 16-22, 1997. |
| Q30426586 | Elucidating the role of neurotensin in the pathophysiology and management of major mental disorders. |
| Q30401944 | Emotion potentiated startle in fragile X syndrome |
| Q73962881 | Establishing norms for age-related changes in proton T1 of human brain tissue in vivo |
| Q80247344 | Evaluation of the ventricular system in children using transcranial ultrasound: reference values for routine diagnostics |
| Q61814927 | Executive Function in Fragile X Syndrome: A Systematic Review |
| Q48300723 | FMR1 gene expression in olfactory neuroblasts from two males with fragile X syndrome |
| Q96126872 | FMRP(1-297)-tat restores ion channel and synaptic function in a model of Fragile X syndrome |
| Q57828399 | Fragile X syndrome |
| Q92575202 | Fragile X syndrome and associated disorders: Clinical aspects and pathology |
| Q36603922 | Fragile X syndrome and autism at the intersection of genetic and neural networks |
| Q41167683 | Fragile X syndrome in humans and mice |
| Q34185158 | Fragile X syndrome. Molecular and clinical insights and treatment issues |
| Q38162720 | Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development |
| Q37122910 | Fragile X syndrome: an aging perspective. |
| Q35661582 | Fragile X syndrome: the GABAergic system and circuit dysfunction |
| Q37900184 | Fragile X-associated disorders: a clinical overview. |
| Q37369973 | Fragile-X: neuropsychological test performance, CGG triplet repeat lengths, and hippocampal volumes |
| Q48201398 | Fronto-striatal dysfunction and potential compensatory mechanisms in male adolescents with fragile X syndrome |
| Q37074462 | Frontostriatal deficits in fragile X syndrome: relation to FMR1 gene expression |
| Q33518804 | Gene, brain, and behavior relationships in fragile X syndrome: evidence from neuroimaging studies |
| Q37853118 | Heads-up: new roles for the fragile X mental retardation protein in neural stem and progenitor cells |
| Q57317054 | Imaging genetics in neurodevelopmental psychopathology |
| Q57512433 | Infant cerebral ventricle volume: a comparison of 3-D ultrasound and magnetic resonance imaging |
| Q38292612 | Input transformation by dendritic spines of pyramidal neurons |
| Q37450139 | Insights into brain development from neurogenetic syndromes: evidence from fragile X syndrome, Williams syndrome, Turner syndrome and velocardiofacial syndrome |
| Q34984581 | Insular volume reduction in fragile X syndrome |
| Q35294197 | Isolated mild fetal ventriculomegaly |
| Q48818692 | Mildly impaired water maze performance in male Fmr1 knockout mice. |
| Q33537385 | Molecular and cellular genetics of fragile X syndrome |
| Q38627691 | Molecular medicine of fragile X syndrome: based on known molecular mechanisms |
| Q33829145 | Morphometric spatial patterns differentiating boys with fragile X syndrome, typically developing boys, and developmentally delayed boys aged 1 to 3 years |
| Q39695230 | Neocortical development as an evolutionary platform for intragenomic conflict |
| Q36874111 | Neural phenotypes of common and rare genetic variants |
| Q58559930 | Neuroanatomical abnormalities in fragile X syndrome during the adolescent and young adult years |
| Q37411441 | Neuroanatomy of fragile X syndrome is associated with aberrant behavior and the fragile X mental retardation protein (FMRP). |
| Q33971594 | Neurobehavioral phenotype of Klinefelter syndrome |
| Q50313440 | Neuropsychological profiles of FMR-1 premutation and full-mutation carrier females |
| Q35076945 | Of mice and the fragile X syndrome. |
| Q48922822 | Outcome in children with fetal mild ventriculomegaly: a case series. |
| Q35009426 | Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders |
| Q38442124 | Oxytocin: parallel processing in the social brain? |
| Q33859690 | Pathological and neuropathological findings in two males with fragile-X syndrome |
| Q41136711 | Perspectives and molecular diagnosis of the fragile X syndrome. |
| Q38238174 | Perspectives in Pediatric Pathology, Chapter 15. Macrorchidism as the Expression of Several Congenital and Acquired Pathologies |
| Q34446607 | Pharmacological reactivation of inactive genes: the fragile X experience |
| Q48207180 | Postmortem examination of two fragile X brothers with an FMR1 full mutation |
| Q51822525 | Prospects of TAT-mediated protein therapy for fragile X syndrome. |
| Q34364858 | Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. |
| Q35196556 | Regulation of molecular pathways in the Fragile X Syndrome: insights into Autism Spectrum Disorders |
| Q49114886 | Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. |
| Q40630474 | Repetitive and self-injurious behaviors: associations with caudate volume in autism and fragile X syndrome |
| Q30354621 | Sensory processing in autism spectrum disorders and Fragile X syndrome-From the clinic to animal models. |
| Q53366504 | Seventh International Workshop on the Fragile X and X-linked Mental Retardation. |
| Q41290267 | Similarities in genetic mental retardation and neuroteratogenic syndromes |
| Q30712946 | Structural and functional magnetic resonance imaging of autism |
| Q34364379 | Taurine regulation of short term synaptic plasticity in fragile X mice |
| Q34052031 | Teasing apart the heterogeneity of autism: Same behavior, different brains in toddlers with fragile X syndrome and autism |
| Q35061671 | The FMR1 gene and fragile X-associated tremor/ataxia syndrome |
| Q47736409 | The LONI Pipeline Processing Environment |
| Q26766054 | The PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia. |
| Q48217717 | The RNA-binding protein, ZC3H14, is required for proper poly(A) tail length control, expression of synaptic proteins, and brain function in mice. |
| Q74809876 | The fragile X syndrome |
| Q41527060 | The neuropathology of CAG repeat diseases: review and update of genetic and molecular features |
| Q36304058 | The role of glycogen synthase kinase-3 signaling in neurodevelopment and fragile X syndrome |
| Q37410983 | Totally tubular: the mystery behind function and origin of the brain ventricular system. |
| Q36192790 | Trajectories of early brain volume development in fragile X syndrome and autism |
| Q35550078 | Understanding fragile X syndrome: insights from animal models |
| Q35451192 | Volumetric magnetic resonance imaging study of the brain in subjects with sex chromosome aneuploidies |
| Q37626841 | White matter microstructural abnormalities in girls with chromosome 22q11.2 deletion syndrome, Fragile X or Turner syndrome as evidenced by diffusion tensor imaging |
| Q73013123 | X-linked mental retardation |
Search more.